191 related articles for article (PubMed ID: 17962436)
61. RKIP and BRAF aberrations in human nasal polyps and the adjacent turbinate mucosae.
Zaravinos A; Bizakis J; Spandidos DA
Cancer Lett; 2008 Jun; 264(2):288-98. PubMed ID: 18329792
[TBL] [Abstract][Full Text] [Related]
62. Detection of BRAF mutation in metastatic melanoma utilizing cell-transferred cytological smears.
Chen S; Randolph M; Cramer HM; Watkins T; McCullough H; Post KM; Sen JD; Cheng L; Wu HH
Acta Cytol; 2014; 58(5):478-82. PubMed ID: 25359156
[TBL] [Abstract][Full Text] [Related]
63. BRAF mutations are detectable in conjunctival but not uveal melanomas.
Spendlove HE; Damato BE; Humphreys J; Barker KT; Hiscott PS; Houlston RS
Melanoma Res; 2004 Dec; 14(6):449-52. PubMed ID: 15577314
[TBL] [Abstract][Full Text] [Related]
64. Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas.
Shinozaki M; Fujimoto A; Morton DL; Hoon DS
Clin Cancer Res; 2004 Mar; 10(5):1753-7. PubMed ID: 15014028
[TBL] [Abstract][Full Text] [Related]
65. Exon 15 BRAF mutations are uncommon in canine oral malignant melanomas.
Shelly S; Chien MB; Yip B; Kent MS; Theon AP; McCallan JL; London CA
Mamm Genome; 2005 Mar; 16(3):211-7. PubMed ID: 15834638
[TBL] [Abstract][Full Text] [Related]
66. Tandem BRAF mutations in primary invasive melanomas.
Thomas NE; Alexander A; Edmiston SN; Parrish E; Millikan RC; Berwick M; Groben P; Ollila DW; Mattingly D; Conway K
J Invest Dermatol; 2004 May; 122(5):1245-50. PubMed ID: 15140228
[TBL] [Abstract][Full Text] [Related]
67. Cytogenetics of iris melanomas: disparity with other uveal tract melanomas.
Sisley K; Brand C; Parsons MA; Maltby E; Rees RC; Rennie IG
Cancer Genet Cytogenet; 1998 Mar; 101(2):128-33. PubMed ID: 9494614
[TBL] [Abstract][Full Text] [Related]
68. BRAF and GNAQ mutations in melanocytic tumors of the oral cavity.
Cohen Y; Goldenberg-Cohen N; Akrish S; Shani T; Amariglio N; Dratviman-Storobinsky O; Kaplan I; Barshack I; Hirshberg A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Dec; 114(6):778-84. PubMed ID: 23159116
[TBL] [Abstract][Full Text] [Related]
69. Detection of BRAF gene mutation in primary choroidal melanoma tissue.
Malaponte G; Libra M; Gangemi P; Bevelacqua V; Mangano K; D'Amico F; Mazzarino MC; Stivala F; McCubrey JA; Travali S
Cancer Biol Ther; 2006 Feb; 5(2):225-7. PubMed ID: 16410717
[TBL] [Abstract][Full Text] [Related]
70. Late Solitary Extraocular Recurrence From Previously Resected Iris Melanoma.
Fabian ID; Thaung C; AlHarby L; Sisley K; Mudhar HS; Doherty RE; Stacey AW; Arora AK; Cohen VML; Sagoo MS
Am J Ophthalmol; 2017 Sep; 181():97-105. PubMed ID: 28673748
[TBL] [Abstract][Full Text] [Related]
71. Low incidence of minor BRAF V600 mutation-positive subclones in primary and metastatic melanoma determined by sensitive and quantitative real-time PCR.
Kristensen T; Clemmensen O; Hoejberg L
J Mol Diagn; 2013 May; 15(3):355-61. PubMed ID: 23499336
[TBL] [Abstract][Full Text] [Related]
72. [BRAF V600E mutation detection in melanoma patients: clinical and morphological features].
Aksenenko MV; Bekuzarov SS; Ruksha TG
Arkh Patol; 2014; 76(5):38-43. PubMed ID: 25543407
[TBL] [Abstract][Full Text] [Related]
73. BRAF mutation in 'sarcomas': a possible method to detect de-differentiated melanomas.
Cipriani NA; Letovanec I; Hornicek FJ; Mullen JT; Duan Z; Borger DR; Nielsen GP
Histopathology; 2014 Apr; 64(5):639-46. PubMed ID: 24117833
[TBL] [Abstract][Full Text] [Related]
74. The RAS-BRAF kinase pathway is not involved in uveal melanoma.
Kiliç E; Brüggenwirth HT; Verbiest MM; Zwarthoff EC; Mooy NM; Luyten GP; de Klein A
Melanoma Res; 2004 Jun; 14(3):203-5. PubMed ID: 15179189
[TBL] [Abstract][Full Text] [Related]
75. [THE BRAF MUTATION AND THE POSSIBILITIES OF UVEAL MELANOMA METASTASING PROGNOSTIC MARKERS IDENTIFICATION].
Horkovičová K; Markus J; Krčová I; Babál P; Kobzová D; Smolková B
Cesk Slov Oftalmol; 2016; 72(4):149-156. PubMed ID: 27860480
[TBL] [Abstract][Full Text] [Related]
76. Absence of BRAF mutations in UV-protected mucosal melanomas.
Edwards RH; Ward MR; Wu H; Medina CA; Brose MS; Volpe P; Nussen-Lee S; Haupt HM; Martin AM; Herlyn M; Lessin SR; Weber BL
J Med Genet; 2004 Apr; 41(4):270-2. PubMed ID: 15060100
[TBL] [Abstract][Full Text] [Related]
77. Identification of the V600D mutation in Exon 15 of the BRAF oncogene in congenital, benign langerhans cell histiocytosis.
Kansal R; Quintanilla-Martinez L; Datta V; Lopategui J; Garshfield G; Nathwani BN
Genes Chromosomes Cancer; 2013 Jan; 52(1):99-106. PubMed ID: 22996177
[TBL] [Abstract][Full Text] [Related]
78. Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma.
Mar VJ; Wong SQ; Logan A; Nguyen T; Cebon J; Kelly JW; Wolfe R; Dobrovic A; McLean C; McArthur GA
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1117-25. PubMed ID: 25043693
[TBL] [Abstract][Full Text] [Related]
79. Genetic Biomarkers in Melanoma of the Ocular Region: What the Medical Oncologist Should Know.
Bol KF; Donia M; Heegaard S; Kiilgaard JF; Svane IM
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718045
[TBL] [Abstract][Full Text] [Related]
80. [Mutational status of BRAF and histopathological characteristics in cutaneous malignant melanoma].
García A; Lorente C; Elsner B; Avagnina A; Denninghoff V
Medicina (B Aires); 2019; 79(4):265-270. PubMed ID: 31487245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
